Biocryst Pharmaceuticals Inc. (BCRX) Stock Forecast & Predictions

Biocryst Pharmaceuticals Inc. BCRX: $10.19

4505 Emperor Blvd Ste 200, Durham, North Carolina, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: https://www.biocryst.com/

  • Market Cap$1.81B
  • Change (52 Weeks)277.41%
  • Low (52 Weeks)$2.5
  • Biocryst Pharmaceuticals Inc. (BCRX) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 25.00% are on Buy, 25.00% on Sell, and 50.00% Neutral.

    According to the market data, Biocryst Pharmaceuticals Inc. (BCRX) stock price is $10.19 and the 52 weeks low is $2.5, which means the Biocryst Pharmaceuticals Inc. stock price is up 277.41% in the last 12 months.

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Price has been Trending Strongly with an ADX reading of 37.15 as per the Weekly Chart.

    A Upward trend indicates that Biocryst Pharmaceuticals Inc. (BCRX) Stock Price may keep going up, with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 25.00% are indicating that BCRX Stock price might rise further, 25.00% indicating that BCRX Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall BCRX stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Biocryst Pharmaceuticals Inc. (BCRX) is based on 17 Institutional Analyst Ratings where 58.82% are on Strong Buy, 23.53% on Moderate Buy, 17.65% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 17 Institutional Analysts, majority recommended BCRX stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Biocryst Pharmaceuticals Inc..

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Price Prediction By Analysts


    HighLowAverage
    $19.95$9.09$14.85
    $14.8545.7% Upside
    Updated: 2021-04-12 00:00:00

    The Average Price target for BCRX set by the institutional analysts is $14.85 where High Estimate is $19.95, Median $15.3 and Low $9.09.

    The average price target for BCRX by Institutional Analysts is $14.85, which is 45.7% Upside from the current price. So according to the Institutional Analysts, BCRX Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 381,013 investor portfolio.

    Our algorithm has analysed 381,013 investor portfolio with BCRX stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about BCRX and holding their positions hoping for a further rise in the stock price and more profit.

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Forecast Based on News Sentiment


    Neutral
    Based on 1 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of BCRX consisting of positive and negative, it shows that Biocryst Pharmaceuticals Inc. had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so BCRX stock price most likey won't have any reaction to last weeks news coverage.

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    HC Wainwright & Co.BuyMaintained
    RBC CapitalSector PerformMaintained
    HC Wainwright & Co.BuyMaintained
    Evercore ISI GroupOutperformInitiated
    BTIGNeutralInitiated
    BarclaysOverweightUpgraded
    Bank of AmericaBuyUpgraded
    RBC CapitalSector PerformDowngraded
    JMP SecuritiesMarket OutperformMaintained
    BarclaysEqual-WeightMaintained
    Seaport GlobalNeutralInitiated
    RBC CapitalOutperformUpgraded
    BarclaysEqual-WeightInitiated
    RBC CapitalSector PerformInitiated
    JP MorganOverweightUpgraded
    JefferiesBuyUpgraded
    Ladenburg ThalmannBuyInitiated
    JMP SecuritiesMarket OutperformUpgraded
    PiperJaffrayOverweightUpgraded
    JefferiesHoldMaintained
    JMP SecuritiesMarket PerformDowngraded
    Rodman & RenshawBuyMaintained
    JP MorganNeutralDowngraded
    JefferiesBuyDowngraded
    PiperJaffrayNeutralDowngraded
    JefferiesBuyUpgraded
    Bank of AmericaUnderperformDowngraded
    JefferiesHoldMaintained
    JefferiesHoldInitiated
    Bank of AmericaBuyUpgraded
    FBR CapitalOutperformInitiated
    Bank of AmericaNeutralUpgraded
    JP MorganOverweightMaintained
    Bank of AmericaUnderperformMaintained
    JP MorganOverweightInitiated
    Wells FargoOutperformUpgraded
    Brinson PatrickMarket OutperformInitiated
    H.C. WainwrightBuyInitiated
    McNicoll Lewis VlakBuyMaintained
    OppenheimerPerformInitiated
    PiperJaffrayOverweightInitiated
    NeedhamBuyInitiated
    Bank of AmericaUnderperformDowngraded
    Wells FargoMarket PerformDowngraded
    Roth CapitalBuyInitiated
    Bank of AmericaNeutralUpgraded
    JMP SecuritiesMarket OutperformMaintained
    Bank of AmericaUnderperformDowngraded
    Noble FinancialBuyUpgraded
    JMP SecuritiesMarket OutperformUpgraded
    McNicoll Lewis VlakBuyUpgraded
    JMP SecuritiesMarket PerformDowngraded

    Biocryst Pharmaceuticals Inc. (BCRX) Stock Earning Per Share (EPS) Forecast / Estimate


    $-0.261
    The average consensus EPS for BCRX is $-0.261 with a high estimate of $-0.147 and Low of $-0.304 for the period 2021-06-30 and based on 13 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-0.26$-0.2604062020-09-30


    The latest average Earning Per Share Estimate for Biocryst Pharmaceuticals Inc. is $-0.26, which is lower than BCRX's last EPS, $-0.26. This means that Analysts are expecting Biocryst Pharmaceuticals Inc. to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Biocryst Pharmaceuticals Inc..

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $-0.26$-0.2604062020-09-30
    $-0.24$-0.26054882020-06-30
    $-0.24$-0.24752342020-03-31
    $-0.02$-0.26180342019-12-31
    $-0.34$-0.32526782019-09-30
    $-0.34$-0.31622019-06-30
    $-0.28$-0.277664400000000032019-03-31
    $-0.25$-0.25726442018-12-31
    $-0.28$-0.26522018-09-30
    $-0.19$-0.2460752018-06-30
    $-0.26$-0.196352018-03-31
    $-0.2$-0.15752882017-12-31
    $-0.18$-0.189722017-09-30
    $-0.21$-0.191252017-06-30
    $-0.19$-0.18872017-03-31
    $-0.06$-0.238680000000000032016-12-31
    $-0.16$-0.2460752016-09-30
    $-0.22$-0.26293562016-06-30
    $-0.31$-0.237662016-03-31
    $-0.25$-0.26012015-12-31
    $-0.2$-0.208082015-09-30
    $0.06$-0.225532200000000022015-06-30
    $-0.21$-0.252452015-03-31
    $-0.16$-0.21504662014-12-31
    $-0.12$-0.20478542014-09-30
    $-0.23$-0.19209662014-06-30
    $-0.17$-0.174532200000000032014-03-31
    $-0.09$-0.090667799999999992013-12-31
    $-0.14$-0.110162013-09-30
    $-0.23$-0.137700000000000022013-06-30
    $-0.09$-0.150452013-03-31
    $-0.18$-0.16322012-12-31
    $-0.19$-0.25160342012-09-30
    $-0.25$-0.26522012-06-30
    $-0.13$-0.26859662012-03-31
    $-0.29$-0.290699999999999962011-12-31
    $-0.32$-0.26349662011-09-30
    $-0.34$-0.259080000000000032011-06-30
    $-0.26$-0.206040000000000032011-03-31
    $-0.2$-0.216242010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).